Research, Studies & Clinical Trials

Fertility patch study for women who have never had a menstrual period

Full Title A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating Three Doses of Subcutaneous Pulsatile GnRH Administered via OmniPod Pump for Ovulation Induction in Female Subjects with Primary Amenorrhea with Hypogonadotropic Hypogonadism
Short Title LutrePulse OmniPod Hypo Hypo Study
COMIRB # Western IRB – 13-352
Description Study of a possible fertility patch for women who are hypo hypo (never had a menstrual period)
Who is eligible Women with Hypo Hypo who pass clinical lab criteria.
Compensation provided Yes
Primary Investigator Dr. Nanette Santoro
Sponsor Ferring Pharmaceuticals
Contact Celeste Robledo, email or call 303-724-2013


Are you stopping your birth control because you want to become pregnant?

Full Title Fertility After Contraceptive Termination: The FACT Study
Short Title FACT
COMIRB # 13-1594
Description Examine conception rates after contraception termination
Who is eligible Women 18-35 who are planning to, or have recently stopped their birth control because they want to become pregnant.
Compensation provided Yes
Primary Investigator Dr. Stephanie Teal
Sponsor Washington University, St. Louis
Contact Sandra Cano, email or call 303-724-2013


Bothersome Bleeding while using Implanon or Nexplanon

Full Title Does concomitant use of combined oral hormonal steroids stop bleeding in women using etonogestrel implants (Implanon/Nexplanon)?: A randomized controlled study
Short Title Implant Bleeding
COMIRB # 13-1702
Description Study on a potential treatment for bothersome bleeding/spotting related to the etonogestrel implant.
Who is eligible Women 18-44 who are experiencing bothersome bleeding/spotting while using Implanon or Nexplanon
Compensation provided Yes
Primary Investigator Dr. Maryam Guiahi
Sponsor American College of Obstetricians & Gynecologists and Ferring Pharmaceutical Inc. Research Fellowship in Menstrual Bleeding Disorders
Contact Sandra Cano, email or call 303-724-2013


Birth Control Hormone Therapy for Perimenopause Treatment Research Study

Full Title Effectiveness of Perimenopausal Hormone Therapy in Suppression of Ovulation, Stabilization of Reproductive Hormones, and Symptom Control
Short Title Bayer-Perimenopausal
COMIRB # 11-1711
Description Study to determine effectiveness of perimenopausal hormone therapy (Mirena intrauterine device alone and in conjunction with estradiol gel) in suppression of ovulation, stabilization of reproductive hormones, and symptom relief in perimenopausal women
Who is eligible Women ages 40–52 with regular periods and any of the following symptoms of perimenopause

  • Hot flashes
  • Cyclical bloating, mood changes or headache
  • Trouble sleeping
Compensation provided Yes
Primary Investigator Dr. Nanette Santoro
Sponsor Bayer Corporation
Contact Christina Gavito, email or call 303-501-4157


 Contact Our Research Staff 

Our Research Staff

Family Planning research staff

Email: [email protected]

Study Cell 1: (303) 501-4157

Study Cell 2: (720) 505-7413

OB/GYN research staff